Venrock Healthcare Capital Partners II L.P. 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 8:32 pm Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Venrock Healthcare Capital Partners II L.P. | 0 0.000% | -4,563,962 (Position Closed) | Filing |
| 2022-02-14 4:13 pm Purchase | 2021-01-19 | 13G | Aclaris Therapeutics, Inc. ACRS | Venrock Healthcare Capital Partners II L.P. | 4,563,962 7.500% | 4,563,962 (New Position) | Filing |